The Management Board of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA ("Issuer", "Company") informs that on 21 September 2018 the following arrangement obligations were paid:
- PLN 3,000,000 to PARP, in accordance with annex of September 19, 2018 to the Agreement of September 21, 2017, which the Issuer announced in No. 28/2018
- PLN 900,000 as repayment of 10% of the capital of Series A bonds issued by the Company (payment of the Issuer by the account of KDPW SA, payment by KDPW SA to the bondholders will take place on September 24, 2018). The next repayment of the 70% bond capital is planned for 22 September 2019.
The arrangement liabilities are repaid in a timely manner, in accordance with the terms of the Agreement of 10 June 2016 and the schedule agreed with PARP.
The repayment was made from own funds, which means a further significant reduction of the Company's debt.
Legal basis - art. 17 sec. 1 of Regulation (EU) No 596/2014 of the European Parliament and of the Council (MAR).
Source: company website, investor relations, current and periodic reports.